It is well known that India is a region of the world where clinical research is on the rise. There are many incentives for conducting research in India, including its huge population of treatment-naïve patients and lower cost of conducting trials. It’s estimated that by 2010, the clinical research market in India will reach 0-600 million (1) .That growth has also brought a tremendous amount of regulatory oversight and safety measures to protect the rights of patients. But that
Comments (0)
Posting Komentar